Dr. Alan W. Skolnick

Urology
Memorial Urology Associates P.A.
915 Gessner Rd Ste 720, 
Houston, TX 
Memorial Urology Associates P.A.
915 Gessner Rd Ste 720, 
Houston, TX 

Overview

Alan Skolnick is a Urologist practicing medicine in Houston, Texas.

His clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), and Acute Cystitis.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 4 clinical trials.

Specialties

Urology

Licenses

Urology in TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Memorial Urology Associates P.A.
915 Gessner Rd Ste 720, Houston, TX 77024

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
Enrollment Status: Terminated
Publish Date: June 23, 2026
Intervention Type: Drug, Other
Study Drug: Deupirfenidone
Study Phase: Phase 2
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
Enrollment Status: Completed
Publish Date: April 18, 2023
Intervention Type: Drug
Study Drug: VERU-111
Study Phase: Phase 3
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Abivertinib
Study Phase: Phase 2
View 3 Less Clinical Trials

3 Total Publications

Evaluation of the potential of Rejuveinix plus dexamethasone against sepsis.
Evaluation of the potential of Rejuveinix plus dexamethasone against sepsis.
Journal: Future microbiology
Published: September 02, 2022
Similar Doctors
Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

Office

1515 Holcombe Blvd Unit 1373, 
Houston, TX 
 (8.1 miles away)
713-792-3250
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Surena Matin is a Urologist practicing medicine in Houston, Texas. Dr. Matin is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

Office

1515 Holcombe Blvd Unit 1373, 
Houston, TX 
 (8.1 miles away)
713-792-3250
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jose Karam is a Urologist practicing medicine in Houston, Texas. Dr. Karam is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Reconstructive Urology Surgery.

Expertise in
17
conditions
Dr. Larry I. Lipshultz
Urology | Reproductive Medicine
Expertise in
17
conditions
Dr. Larry I. Lipshultz
Urology | Reproductive Medicine
Referral may be required
Before you request

Baylor Medicine At McNair - Urology

7200 Cambridge St., 10th Floor, Suite 10 B, 
Houston, TX 
 (8.7 miles away)
713-798-4001
Languages Spoken:
English, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Larry I. Lipshultz, M.D., is Professor of Urology and Chief of the Scott Department of Urology’s Division of Male Reproductive Medicine and Surgery. Dr. Lipshultz, who holds the Smith Chair in Reproductive Medicine, is a well-known authority on abnormalities of male reproduction, erectile dysfunction, and male hormone production. He received his medical training at the University of Pennsylvania and received fellowship training at the University of Texas at Houston as the first AUA research scholar. Recognized as a leading expert on men’s health, Dr. Lipshultz is a highly respected author and editor, as well as lecturer. Teacher as well as physician, researcher, writer, and editor, Dr. Lipshultz instituted a fellowship training program in male reproductive medicine and surgery that has trained more than 80 physicians who are now in practice both here and abroad. Dr. Lipshultz is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Peyronie Disease, Hypogonadism, Infertility, Vasectomy, and Hormone Replacement Therapy (HRT). Dr. Lipshultz is currently accepting new patients.

Frequently Asked Questions about Dr. Alan W. Skolnick

How do I make an appointment with Dr. Alan W. Skolnick?

You can book an appointment with Dr. Alan W. Skolnick by calling their office at 713-830-9100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Alan W. Skolnick a top-rated expert for Urinary Tract Infection in Children?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alan W. Skolnick is classified as an Experienced expert for Urinary Tract Infection in Children, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Alan W. Skolnick specialize in?

While Dr. Alan W. Skolnick is a Urology, they have specific expertise in Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Enlarged Prostate (BPH). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Alan W. Skolnick participate in research or clinical trials?

Yes. Dr. Alan W. Skolnick has published 3 articles and abstracts on conditions like Urinary Tract Infection in Children. You can view a list of Dr. Alan W. Skolnick's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Alan W. Skolnick accept my insurance?

Dr. Alan W. Skolnick accepts most major insurance plans, including Blue Cross Blue Shield and Medicare. We recommend calling the office directly at 713-830-9100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Skolnick's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile